Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Stephen E. Barry. (2008) Challenges in the development of magnetic particles for therapeutic applications. International Journal of Hyperthermia 24:6, pages 451-466.
Read now
Read now
Articles from other publishers (18)
Jürgen Weinreich, Florian Struller, Iaroslav Sautkin, Shalva Giuashvili, Marc Reymond, Alfred Königsrainer & Timm C. Schott. (2018) Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro. Investigational New Drugs 37:3, pages 415-423.
Crossref
Crossref
A. M. Dueckelmann, D. Fink, P. Harter, V. Heinzelmann, C. Marth, M. Mueller, A. Reinthaller, K. Tamussino, P. Wimberger & J. Sehouli. (2018) The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the German “Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)”, the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology. Archives of Gynecology and Obstetrics 297:4, pages 837-846.
Crossref
Crossref
Alaa A. Elzarkaa, Waleed Shaalan, Doaa Elemam, Hassan Mansour, Mahmoud Melis, Eduard Malik & Amr A. Soliman. (2018) Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study. Journal of Gynecologic Oncology 29:4.
Crossref
Crossref
Alireza Aminsharifi, Pooya Hekmati, Ali Noorafshan, Saied Karbalay-Doost, Elham Nadimi, Ali Aryafar, Omid Koohi Hosseinabadi, Mohammad Mehdi Naseri & Mohsen ZarePoor. (2016) Scrotal Cooling to Protect Against Cisplatin-induced Spermatogenesis Toxicity: Preliminary Outcome of an Experimental Controlled Trial. Urology 91, pages 90-98.
Crossref
Crossref
Luis M. Chiva & Antonio Gonzalez-Martin. (2015) A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer. Gynecologic Oncology 136:1, pages 130-135.
Crossref
Crossref
P. Mallmann & M. Wirtz. (2014) Pharma Update GenitalkarzinomePharmacotherapy update genital cancer. Der Gynäkologe 47:7, pages 490-495.
Crossref
Crossref
Anna Fagotti, Valerio Gallotta, Federico Romano, Francesco Fanfani, Cristiano Rossitto, Giuseppe Vizzielli, Barbara Costantini & Giovanni Scambia. (2010) Role of cytoreductive surgery in recurrent ovarian cancer. Therapy 7:1, pages 87-95.
Crossref
Crossref
A. Fagotti, I. Paris, F. Grimolizzi, F. Fanfani, G. Vizzielli, A. Naldini & G. Scambia. (2009) Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: A pilot study. Gynecologic Oncology 113:3, pages 335-340.
Crossref
Crossref
C. W. Helm, C. R. Toler, R. S. Martin, M. E. Gordinier, L. P. Parker, D. S. Metzinger & R. P. Edwards. (2007) Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity. International Journal of Gynecologic Cancer 17:1, pages 204-209.
Crossref
Crossref
C. William Helm. 2007. Intraperitoneal Cancer Therapy. Intraperitoneal Cancer Therapy
147
161
.
J. Gori, R. CastanO, M. Toziano, D. Habich, J. Staringer, D.G.B. De Quiros & N. Felci. (2005) Intraperitoneal hyperthermic chemotherapy in ovarian cancer. International Journal of Gynecological Cancer 15:2, pages 233-239.
Crossref
Crossref
Mitsuhiko Akaboshi, Kenichi Kawai, Yoshiko Tanaka, Jitsuya Takada & Noriko Fujii. (1999) Cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules of hela cells treated with combinations of hyperthermia and cisdiamine (glycolato)platinum(II). Biological Trace Element Research 71-72:1, pages 585-593.
Crossref
Crossref
M. Akaboshi, K. Kawai, Y. Tanaka, J. Takada & T. Sumino. (1999) Cell-killing efficiency and number of platinum atoms binding to DNA, RNA and protein molecules of HeLa cells treated with combinations of hyperthermia and carboplatin. Journal of Radioanalytical and Nuclear Chemistry 239:2, pages 405-409.
Crossref
Crossref
P.J.M. van de Vaart, N. van der Vange, F.A.N Zoetmulder, A.R. van Goethem, O. van Tellingen, W.W. ten Bokkel Huinink, J.H. Beijnen, H. Bartelink & A.C. Begg. (1998) Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin–DNA adduct formation in patients and ovarian cancer cell lines. European Journal of Cancer 34:1, pages 148-154.
Crossref
Crossref
Radmila Milačič, Maja Čemažar & Gregor Serša. (1997) Determination of platinum in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry. Journal of Pharmaceutical and Biomedical Analysis 16:2, pages 343-348.
Crossref
Crossref
Mitsuhiko Akaboshi, Kenichi Kawai, Yuko Kinashi, Shinichiro Masunaga & Koji Ono. (2005) Cell‐killing Efficiency and Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HeLa Cells Treated with Combinations of trans‐Diammedichloroplatinum(II) and Hyperthermia. Japanese Journal of Cancer Research 88:5, pages 506-511.
Crossref
Crossref
S Masunaga, K Ono, M Suzuki, M Takagaki, Y Sakurai, T Kobayashi, K Akuta, M Akaboshi, Y Kinashi & M Abe. (1997) Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.. The British Journal of Radiology 70:832, pages 391-398.
Crossref
Crossref
Chris van Bree, Ron C. Rietbroek, Esther M. Schopman, J.Bart A. Kipp & Piet J.M. Bakker. (1996) Local hyperthermia enhances the effect of cis-diamminedichloro-platinum(II) on nonirradiated and preirradiated rat solid tumors. International Journal of Radiation Oncology*Biology*Physics 36:1, pages 135-140.
Crossref
Crossref